(Q48713880)

14 February 2018

title

Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients. (English)

1 reference

14 February 2018

0 references

Scinto LF

1

1 reference

14 February 2018

Frosch M

2

1 reference

14 February 2018

Wu CK

3

1 reference

14 February 2018

Daffner KR

4

1 reference

14 February 2018

Gedi N

5

1 reference

14 February 2018

Geula C

6

1 reference

14 February 2018

publication date

1 September 2001

1 reference

14 February 2018

published in

Neurobiology of Aging

1 reference

14 February 2018

volume

22

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

page(s)

729-736

1 reference

14 February 2018

Pupil dilatation assay by tropicamide is modulated by apolipoprotein E epsilon 4 allele dosage in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Neuropathological stageing of Alzheimer-related changes

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Is videopupillography useful in the diagnosis of Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Response of the pupil to tropicamide is not a reliable test for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The pupillary response to tropicamide in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The edinger-westphal nucleus: Sources of input influencing accommodation, pupilloconstriction, and choroidal blood flow

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Pupil response to tropicamide in Alzheimer's disease and other neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Tropicamide eyedrops cannot be used for reliable diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The Oregon brain aging study: neuropathology accompanying healthy aging in the oldest old.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Pupil dilation to tropicamide is not specific for Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Enhanced miotic response to topical dilute pilocarpine in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The peripheral and central projections of the Edinger-Westphal nucleus in the rat. A light and electron microscopic tracing study.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

[Hypersensitivity in the pupil dilation response to a cholinergic antagonist in patients with Alzheimer's disease and Down's syndrome]

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Transneuronal retinal input to the primate Edinger-Westphal nucleus.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Pupil dilation response to tropicamide: a biological test for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Can tropicamide eye drop response differentiate patients with progressive supranuclear palsy and Alzheimer's disease from healthy control subjects?

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Re-evaluation of the efferent projections of the Edinger-Westphal nucleus in the cat

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Pupillary response to tropicamide in patients with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Detecting Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Very mild Alzheimer's disease: informant-based clinical, psychometric, and pathologic distinction from normal aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Cerebral amyloid deposition and diffuse plaques in "normal" aging: Evidence for presymptomatic and very mild Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

The mydriatic effect of tropicamide and its diagnostic use in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

A potential noninvasive neurobiological test for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Focal pathology in the Edinger-Westphal nucleus explains pupillary hypersensitivity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

Pupillary response to topical tropicamide as a marker for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2801%2900235-4

7 January 2021

10.1016/S0197-4580(01)00235-4

Identifiers

DOI

1 reference

14 February 2018

1 reference

14 February 2018